1-2 of 2
Boullanger FOW HENG Nadine
Close
Sort by
Journal Articles

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group

Zofia Gross, Urbain Tauveron-Jalenques, Gaspar Aspas Requena, Martin Carre, Mathieu Meunier, Emmanuelle Tavernier, Jérôme Cornillon, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Boullanger FOW HENG Nadine, Daciana Claudia Antal, Gian Matteo Pica, Dony Arthur, Clémence Santana, Clement Rocher, Mael Heiblig
Journal: Blood
Blood (2023) 142 (Supplement 1): 590.
https://doi.org/10.1182/blood-2023-187331
Published: 2023
Journal Articles

Lost and Gain of t(4;14) and t(11;14) in Multiple Myeloma Patients Between Relapse and diagnosis: An Illustration of Clonal Dynamic During Disease Course. an IFM Study

Benjamin Hebraud, MD, Denis Caillot, M.D., Jill Corre, Gerald Marit, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD, Marc Wetterwald, MD, PhD, Mamoun Dib, MD, Philippe Rodon, MD, Laurent Voillat, MD, Bruno Royer, MD, Eric G. Voog, MD, Anne-Marie Stoppa, MD, Laurent Garderet, MD, Brigitte Kolb, MD, Michel Maigre, MD, Boullanger FOW HENG Nadine, Olivier Allangba, Thierry Facon, MD, Claire Mathiot, MD, Michel Attal, MD, Philippe Moreau, MD, Herve avet-Loiseau, MD
Journal: Blood
Blood (2012) 120 (21): 196.
https://doi.org/10.1182/blood.V120.21.196.196
Published: 2012